All articles by Gujjarlapudi Satish

  1. Astellas initiates trial to evaluate VMS therapy fezolinetant

    Astellas Pharma has initiated the SKYLIGHT 1 Phase III trial to evaluate fezolinetant for the treatment of moderate-to-severe vasomotor symptoms…
    Read More…

    6 Aug
  2. Lilly reports positive data from CONQUER study of Emgality

    Eli Lilly and Company has reported positive data from the Phase III CONQUER study of Emgality (galcanezumab-gnlm) in patients who…
    Read More…

    6 Aug
  3. Genentech reports positive data from cancer immunotherapy trial

    Roche Group member Genentech has reported positive results from the Phase III IMvigor130 combination trial of Tecentriq (Atezolizumab) and platinum-based…
    Read More…

    5 Aug
  4. Pfizer’s RESET trial of rivipansel fails to meet endpoints

    Pfizer’s Phase III Rivipansel (GMI-1070) Evaluating Safety, Efficacy and Time to Discharge (RESET) pivotal trial has failed to meet its…
    Read More…

    5 Aug
  5. Boehringer reports positive data from afatinib’s real-world study

    Boehringer Ingelheim has reported positive interim results from the real-world GioTag study of afatinib (Giotrif/Gilotrif) in EGFR Del19 and T790M…
    Read More…

    5 Aug
  6. New respiratory syncytial virus vaccine shows promise in Phase I trial

    An experimental vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) to protect against respiratory syncytial virus…
    Read More…

    2 Aug
  7. AAV gene therapy shows positive results in Batten disease trial

    Amicus Therapeutics has announced interim data from a Phase I/II clinical trial of an AAV gene therapy for the treatment…
    Read More…

    2 Aug
  8. Novartis’ Kisqali improves survival in MONALEESA-3 participants

    Novartis has announced that the Phase III MONALEESA-3 study of Kisqali (ribociclib) has met its key secondary endpoint at interim…
    Read More…

    2 Aug
  9. Biohaven initiates enrolment in verdiperstat’s study for MSA

    Biohaven Pharmaceutical has started patient enrolment in a Phase III clinical trial being conducted to assess verdiperstat for the treatment…
    Read More…

    1 Aug
  10. XBiotech to launch bermekimab study to treat hidradenitis suppurativa

    XBiotech has plans to advance its dermatology programme for its human antibody bermekimab with the commencement of a Phase IIb…
    Read More…

    24 May
Close
Close
Close

Go Top